Share
Menopausal symptoms – hot flushes and night sweats – experienced by women with breast cancer can be reduced through group cognitive behavioural therapy (CBT) delivered by breast care nurses, a new clinical trial involving the Southampton Clinical Trials Unit has revealed.
Up to 85% of women with breast cancer suffer from hot flushes and night sweats due to chemotherapy and hormone therapy treatments. These side effects are often more extreme and can last longer for women with breast cancer than for women who experience them due to natural menopause. Hormone replacement therapy (HRT) may be offered to relieve menopausal symptoms, but is not usually recommended for women with breast cancer because it may increase their risk of the disease returning, therefore safe and effective alternatives to reduce side effects and ensure quality of life are urgently needed.
Date Time
Nurse-led cognitive behavioural therapy can reduce “overwhelming” menopausal symptoms for women with breast cancer
Menopausal symptoms – hot flushes and night sweats – experienced by women with breast cancer can be reduced through group cognitive behavioural therapy (CBT) delivered by breast care nurses, a new clinical trial involving the Southampton Clinical Trials Unit has revealed.
Up to 85% of women with breast cancer suffer from hot flushes and night sweats due to chemotherapy and hormone therapy treatments. These side effects are often more extreme and can last longer for women with breast cancer than for women who experience them due to natural menopause. Hormone replacement therapy (HRT) may be offered to relieve menopausal symptoms, but is not usually recommended for women with breast cancer because it may increase their risk of the disease returning, therefore safe and effective alternatives to reduce side effects and ensure quality of life are urgently
Anyone who suffers from acne will probably understand me when I say I have tried every medication possible to treat it. I feel like I have sat in more dermatology centres than anyone else, taken countless oral antibiotics and experimented with numerous topical retinoids and solutions.
At the age of seventeen, I had exhausted all my options. I had been prescribed with antibiotics, the combined pill, numerous creams and finally isotretinoin (also known as Roaccutane).
However, it is becoming evident that antibiotics and oral contraceptives may not be the best option to treat acne.
That’s why an ongoing trial run by Southampton Clinical Trials Unit (SCTU), looking into the use of steroid spironolactone, is such a promising possible alternative for women across the globe.
Nivolumab Improves Survival in Relapsed Mesothelioma medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
E-Mail
(Singapore January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST) Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.
Malignant mesothelioma is an intractable cancer, and no phase III trial has yet shown an improvement in overall survival following the standard first line chemotherapy doublet comprising pemetrexed and cisplatin or carboplatin since it was licensed in 2004.
Professor Dean Fennell, chair of Thoracic Medical Oncology at the University of Leicester in collaboration with Professor Gareth Griffiths and his team at the Southampton Clinical Trials Unit, University of Southampton, UK, presented results of the Checkpoint Blockade for Inhibition of Relapsed Mesothelioma (CONFIRM) study, funded by Cancer Research UK/Stand Up To Cancer. The investigator-led, placebo-controlled rando